-
1
-
-
80052270947
-
The epidemiology of renal cell carcinoma
-
doi:10.1016/j.eururo.2011.06.049
-
Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, et al. (2011) The epidemiology of renal cell carcinoma. Eur Urol 60: 615-621. doi:10.1016/j.eururo.2011.06.049. PubMed: 21741761.
-
(2011)
Eur Urol
, vol.60
, pp. 615-621
-
-
Ljungberg, B.1
Campbell, S.C.2
Choi, H.Y.3
Jacqmin, D.4
Lee, J.E.5
-
2
-
-
0031255567
-
The Heidelberg classification of renal cell tumours
-
doi:10.1002/(SICI)1096-9896(199710)183:2
-
Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, et al. (1997) The Heidelberg classification of renal cell tumours. J Pathol 183: 131-133. doi:10.1002/(SICI)1096-9896(199710)183:2. PubMed: 9390023.
-
(1997)
J Pathol
, vol.183
, pp. 131-133
-
-
Kovacs, G.1
Akhtar, M.2
Beckwith, B.J.3
Bugert, P.4
Cooper, C.S.5
-
3
-
-
0030853434
-
Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)
-
doi:10.1002/(SICI)1097-0142(19970901)80:5
-
Störkel S, Eble JN, Adlakha K, Amin M, Blute ML, et al. (1997) Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80: 987-989. doi:10.1002/(SICI)1097-0142(19970901)80:5. PubMed: 9307203.
-
(1997)
Cancer
, vol.80
, pp. 987-989
-
-
Störkel, S.1
Eble, J.N.2
Adlakha, K.3
Amin, M.4
Blute, M.L.5
-
4
-
-
78649347932
-
Evaluation and management of the renal mass
-
doi:10.1016/j.mcna.2010.08.021
-
Chen DY, Uzzo RG, (2011) Evaluation and management of the renal mass. Med Clin North Am 95: 179-189. doi:10.1016/j.mcna.2010.08.021. PubMed: 21095421.
-
(2011)
Med Clin North Am
, vol.95
, pp. 179-189
-
-
Chen, D.Y.1
Uzzo, R.G.2
-
5
-
-
77955635233
-
Cancer statistics, 2010
-
doi:10.3322/caac.20073
-
Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300. doi:10.3322/caac.20073. PubMed: 20610543.
-
(2010)
CA Cancer J Clin
, vol.60
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
Ward, E.4
-
6
-
-
65949091346
-
Targeting mTOR in renal cell carcinoma
-
doi:10.1002/cncr.24239
-
Hudes GR, (2009) Targeting mTOR in renal cell carcinoma. Cancer 115: 2313-2320. doi:10.1002/cncr.24239. PubMed: 19402072.
-
(2009)
Cancer
, vol.115
, pp. 2313-2320
-
-
Hudes, G.R.1
-
7
-
-
77957997621
-
Targeted therapies for renal cell carcinoma: understanding their impact on survival
-
doi:10.1007/s11523-010-0145-6
-
Pal SK, Figlin RA, (2010) Targeted therapies for renal cell carcinoma: understanding their impact on survival. Target Oncol 5: 131-138. doi:10.1007/s11523-010-0145-6. PubMed: 20632214.
-
(2010)
Target Oncol
, vol.5
, pp. 131-138
-
-
Pal, S.K.1
Figlin, R.A.2
-
8
-
-
79955689582
-
Targeted-therapy in advanced renal cell carcinoma
-
doi:10.2174/092986711795471293
-
Pirrotta MT, Bernardeschi P, Fiorentini G, (2011) Targeted-therapy in advanced renal cell carcinoma. Curr Med Chem 18: 1651-1657. doi:10.2174/092986711795471293. PubMed: 21428882.
-
(2011)
Curr Med Chem
, vol.18
, pp. 1651-1657
-
-
Pirrotta, M.T.1
Bernardeschi, P.2
Fiorentini, G.3
-
9
-
-
84856159566
-
Targeted therapies for renal cell carcinoma: review of adverse event management strategies
-
doi:10.1093/jnci/djr511
-
Eisen T, Sternberg CN, Robert C, Mulders P, Pyle L, et al. (2012) Targeted therapies for renal cell carcinoma: review of adverse event management strategies. J Natl Cancer Inst 104: 93-113. doi:10.1093/jnci/djr511. PubMed: 22235142.
-
(2012)
J Natl Cancer Inst
, vol.104
, pp. 93-113
-
-
Eisen, T.1
Sternberg, C.N.2
Robert, C.3
Mulders, P.4
Pyle, L.5
-
10
-
-
77952263737
-
The genetic basis of kidney cancer: a metabolic disease
-
doi:10.1038/nrurol.2010.47
-
Linehan WM, Srinivasan R, Schmidt LS, (2010) The genetic basis of kidney cancer: a metabolic disease. Nat. Rev Urol 7: 277-285. doi:10.1038/nrurol.2010.47.
-
(2010)
Nat Rev Urol
, vol.7
, pp. 277-285
-
-
Linehan, W.M.1
Srinivasan, R.2
Schmidt, L.S.3
-
11
-
-
2942689618
-
The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma
-
doi:10.1152/ajpheart.00952.2003
-
Sufan RI, Jewett MA, Ohh M, (2004) The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma. Am J Physiol Renal Physiol 287: F1-F6. doi:10.1152/ajpheart.00952.2003. PubMed: 15180922.
-
(2004)
Am J Physiol Renal Physiol
, vol.287
-
-
Sufan, R.I.1
Jewett, M.A.2
Ohh, M.3
-
12
-
-
45249124315
-
Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor
-
doi:10.1042/BST0360472
-
Nyhan MJ, O'Sullivan GC, McKenna SL, (2008) Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor. Biochem Soc Trans 36: 472-478. doi:10.1042/BST0360472. PubMed: 18481984.
-
(2008)
Biochem Soc Trans
, vol.36
, pp. 472-478
-
-
Nyhan, M.J.1
O'Sullivan, G.C.2
McKenna, S.L.3
-
13
-
-
84861845402
-
The updated biology of hypoxia-inducible factor
-
doi:10.1038/emboj.2012.125
-
Greer SN, Metcalf JL, Wang Y, Ohh M, (2012) The updated biology of hypoxia-inducible factor. EMBO J 31: 2448-2460. doi:10.1038/emboj.2012.125. PubMed: 22562152.
-
(2012)
EMBO J
, vol.31
, pp. 2448-2460
-
-
Greer, S.N.1
Metcalf, J.L.2
Wang, Y.3
Ohh, M.4
-
14
-
-
80053357273
-
The emerging role of nuclear factor kappa B in renal cell carcinoma
-
doi:10.1016/j.biocel.2011.08.003
-
Morais C, Gobe G, Johnson DW, Healy H, (2011) The emerging role of nuclear factor kappa B in renal cell carcinoma. Int J Biochem Cell Biol 43: 1537-1549. doi:10.1016/j.biocel.2011.08.003. PubMed: 21854869.
-
(2011)
Int J Biochem Cell Biol
, vol.43
, pp. 1537-1549
-
-
Morais, C.1
Gobe, G.2
Johnson, D.W.3
Healy, H.4
-
15
-
-
0242694963
-
The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway
-
Qi H, Ohh M, (2003) The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway. Cancer Res 63: 7076-7080. PubMed: 14612498.
-
(2003)
Cancer Res
, vol.63
, pp. 7076-7080
-
-
Qi, H.1
Ohh, M.2
-
16
-
-
23844527189
-
Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity
-
doi:10.1128/MCB.25.17.7546-7556.2005
-
An J, Rettig MB, (2005) Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity. Mol Cell Biol 25: 7546-7556. doi:10.1128/MCB.25.17.7546-7556.2005. PubMed: 16107702.
-
(2005)
Mol Cell Biol
, vol.25
, pp. 7546-7556
-
-
An, J.1
Rettig, M.B.2
-
17
-
-
34948883495
-
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2
-
doi:10.1016/j.molcel.2007.09.010
-
Yang H, Minamishima YA, Yan Q, Schlisio S, Ebert BL, et al. (2007) pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2. Mol Cell 28: 15-27. doi:10.1016/j.molcel.2007.09.010. PubMed: 17936701.
-
(2007)
Mol Cell
, vol.28
, pp. 15-27
-
-
Yang, H.1
Minamishima, Y.A.2
Yan, Q.3
Schlisio, S.4
Ebert, B.L.5
-
18
-
-
33846805694
-
Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib
-
doi:10.1186/1476-4598-6-61
-
An J, Rettig MB, (2007) Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib. Mol Cancer Ther 6: 61-69. doi:10.1186/1476-4598-6-61. PubMed: 17237266.
-
(2007)
Mol Cancer Ther
, vol.6
, pp. 61-69
-
-
An, J.1
Rettig, M.B.2
-
19
-
-
44049107707
-
Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody
-
doi:10.1093/jnci/djn113
-
Shanker A, Brooks AD, Tristan CA, Wine JW, Elliott PJ, et al. (2008) Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody. J Natl Cancer Inst 100: 649-662. doi:10.1093/jnci/djn113. PubMed: 18445820.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 649-662
-
-
Shanker, A.1
Brooks, A.D.2
Tristan, C.A.3
Wine, J.W.4
Elliott, P.J.5
-
20
-
-
77952944929
-
Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex
-
doi:10.1158/1541-7786.MCR-10-0022
-
Brooks AD, Jacobsen KM, Li W, Shanker A, Sayers TJ, (2010) Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex. Mol Cancer Res 8: 729-738. doi:10.1158/1541-7786.MCR-10-0022. PubMed: 20442297.
-
(2010)
Mol Cancer Res
, vol.8
, pp. 729-738
-
-
Brooks, A.D.1
Jacobsen, K.M.2
Li, W.3
Shanker, A.4
Sayers, T.J.5
-
21
-
-
77956929126
-
Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus
-
Roos FC, Roberts AM, Hwang II, Moriyama EH, Evans AJ, et al. (2010) Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus. EMBO. Mol Med 2: 275-288.
-
(2010)
EMBO Mol Med
, vol.2
, pp. 275-288
-
-
Roos, F.C.1
Roberts, A.M.2
Hwang, I.I.3
Moriyama, E.H.4
Evans, A.J.5
-
22
-
-
0142121516
-
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
-
doi:10.1093/biostatistics/4.2.249
-
Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264. doi:10.1093/biostatistics/4.2.249. PubMed: 12925520.
-
(2003)
Biostatistics
, vol.4
, pp. 249-264
-
-
Irizarry, R.A.1
Hobbs, B.2
Collin, F.3
Beazer-Barclay, Y.D.4
Antonellis, K.J.5
-
23
-
-
28744458859
-
Bioconductor: open software development for computational biology and bioinformatics
-
doi:10.1186/gb-2004-5-10-r80
-
Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80. doi:10.1186/gb-2004-5-10-r80. PubMed: 15461798.
-
(2004)
Genome Biol
, vol.5
-
-
Gentleman, R.C.1
Carey, V.J.2
Bates, D.M.3
Bolstad, B.4
Dettling, M.5
-
24
-
-
33751006151
-
RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis
-
doi:10.1093/bioinformatics/btl476
-
Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, et al. (2006) RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22: 2825-2827. doi:10.1093/bioinformatics/btl476. PubMed: 16982708.
-
(2006)
Bioinformatics
, vol.22
, pp. 2825-2827
-
-
Hong, F.1
Breitling, R.2
McEntee, C.W.3
Wittner, B.S.4
Nemhauser, J.L.5
-
25
-
-
4544341015
-
Linear models and empirical bayes methods for assessing differential expression in microarray experiments
-
Article3
-
Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3Article3 PubMed: 16646809.
-
(2004)
Stat Appl Genet Mol Biol
, vol.3
-
-
Smyth, G.K.1
-
26
-
-
77958075147
-
A semi-parametric generalization of the Cox proportional hazards regression model: Inference and Applications
-
doi:10.1016/j.csda.2010.06.010
-
Devarajan K, Ebrahimi N, (2011) A semi-parametric generalization of the Cox proportional hazards regression model: Inference and Applications. Comput Stat Data Anal 55: 667-676. doi:10.1016/j.csda.2010.06.010. PubMed: 21076652.
-
(2011)
Comput Stat Data Anal
, vol.55
, pp. 667-676
-
-
Devarajan, K.1
Ebrahimi, N.2
-
27
-
-
70449647008
-
Proportional hazards tests and diagnostics based on weighted residuals
-
doi:10.1093/biomet/81.3.515
-
Grambsch PM, Therneau TM, (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81: 515-526. doi:10.1093/biomet/81.3.515.
-
(1994)
Biometrika
, vol.81
, pp. 515-526
-
-
Grambsch, P.M.1
Therneau, T.M.2
-
28
-
-
0027080802
-
The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis
-
doi:10.1002/sim.4780111409
-
Wei LJ, (1992) The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis. Stat Med 11: 1871-1879. doi:10.1002/sim.4780111409. PubMed: 1480879.
-
(1992)
Stat Med
, vol.11
, pp. 1871-1879
-
-
Wei, L.J.1
-
29
-
-
33644972271
-
On least-squares regression with censored data
-
doi:10.1093/biomet/93.1.147
-
Jin Z, Lin DY, Ying Z, (2006) On least-squares regression with censored data. Biometrika 93: 147-161. doi:10.1093/biomet/93.1.147.
-
(2006)
Biometrika
, vol.93
, pp. 147-161
-
-
Jin, Z.1
Lin, D.Y.2
Ying, Z.3
-
30
-
-
84882256047
-
NF-kappaB Inhibition by Bortezomib Permits Interferon-gamma-Activated RIP1 Kinase-Dependent Necrosis in Renal Cell Carcinoma
-
Thapa RJ, Chen P, Cheung M, Nogusa S, Pei J, et al. (2013) NF-kappaB Inhibition by Bortezomib Permits Interferon-gamma-Activated RIP1 Kinase-Dependent Necrosis in Renal Cell Carcinoma. Mol Cancer Ther.
-
(2013)
Mol Cancer Ther
-
-
Thapa, R.J.1
Chen, P.2
Cheung, M.3
Nogusa, S.4
Pei, J.5
-
31
-
-
34548071005
-
Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma
-
doi:10.1158/1078-0432.CCR-07-0143
-
Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, et al. (2007) Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res 13: 4740-4749. doi:10.1158/1078-0432.CCR-07-0143. PubMed: 17699851.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 4740-4749
-
-
Gumz, M.L.1
Zou, H.2
Kreinest, P.A.3
Childs, A.C.4
Belmonte, L.S.5
-
32
-
-
0344406232
-
Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma
-
doi:10.1093/carcin/24.3.377
-
Oya M, Takayanagi A, Horiguchi A, Mizuno R, Ohtsubo M, et al. (2003) Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 24: 377-384. doi:10.1093/carcin/24.3.377. PubMed: 12663495.
-
(2003)
Carcinogenesis
, vol.24
, pp. 377-384
-
-
Oya, M.1
Takayanagi, A.2
Horiguchi, A.3
Mizuno, R.4
Ohtsubo, M.5
-
33
-
-
14944366562
-
VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism
-
doi:10.1038/sj.onc.1208348
-
An J, Fisher M, Rettig MB, (2005) VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism. Oncogene 24: 1563-1570. doi:10.1038/sj.onc.1208348. PubMed: 15608669.
-
(2005)
Oncogene
, vol.24
, pp. 1563-1570
-
-
An, J.1
Fisher, M.2
Rettig, M.B.3
-
34
-
-
4444376712
-
Signaling to NF-kappaB
-
doi:10.1101/gad.1228704
-
Hayden MS, Ghosh S, (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224. doi:10.1101/gad.1228704. PubMed: 15371334.
-
(2004)
Genes Dev
, vol.18
, pp. 2195-2224
-
-
Hayden, M.S.1
Ghosh, S.2
-
35
-
-
0033596121
-
Activators and target genes of Rel/NF-kappaB transcription factors
-
doi:10.1038/sj.onc.1203239
-
Pahl HL, (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866. doi:10.1038/sj.onc.1203239. PubMed: 10602461.
-
(1999)
Oncogene
, vol.18
, pp. 6853-6866
-
-
Pahl, H.L.1
-
36
-
-
79952384759
-
Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses
-
doi:10.1128/JVI.02213-10
-
Basagoudanavar SH, Thapa RJ, Nogusa S, Wang J, Beg AA, et al. (2011) Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses. J Virol 85: 2599-2610. doi:10.1128/JVI.02213-10. PubMed: 21209118.
-
(2011)
J Virol
, vol.85
, pp. 2599-2610
-
-
Basagoudanavar, S.H.1
Thapa, R.J.2
Nogusa, S.3
Wang, J.4
Beg, A.A.5
-
37
-
-
79960363668
-
NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis
-
doi:10.1128/MCB.05445-11
-
Thapa RJ, Basagoudanavar SH, Nogusa S, Irrinki K, Mallilankaraman K, et al. (2011) NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis. Mol Cell Biol 31: 2934-2946. doi:10.1128/MCB.05445-11. PubMed: 21576359.
-
(2011)
Mol Cell Biol
, vol.31
, pp. 2934-2946
-
-
Thapa, R.J.1
Basagoudanavar, S.H.2
Nogusa, S.3
Irrinki, K.4
Mallilankaraman, K.5
-
38
-
-
39749116278
-
Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile
-
doi:10.1186/1476-4598-7-6
-
Cifola I, Spinelli R, Beltrame L, Peano C, Fasoli E, et al. (2008) Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile. Mol Cancer 7: 6. doi:10.1186/1476-4598-7-6. PubMed: 18194544.
-
(2008)
Mol Cancer
, vol.7
, pp. 6
-
-
Cifola, I.1
Spinelli, R.2
Beltrame, L.3
Peano, C.4
Fasoli, E.5
-
39
-
-
3042752912
-
Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data
-
doi:10.1186/1471-2407-3-31
-
Lenburg ME, Liou LS, Gerry NP, Frampton GM, Cohen HT, et al. (2003) Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. BMC Cancer 3: 31. doi:10.1186/1471-2407-3-31. PubMed: 14641932.
-
(2003)
BMC Cancer
, vol.3
, pp. 31
-
-
Lenburg, M.E.1
Liou, L.S.2
Gerry, N.P.3
Frampton, G.M.4
Cohen, H.T.5
-
40
-
-
66749104378
-
High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas
-
doi:10.1186/1471-2407-9-152
-
Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG, et al. (2009) High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer 9: 152. doi:10.1186/1471-2407-9-152. PubMed: 19445733.
-
(2009)
BMC Cancer
, vol.9
, pp. 152
-
-
Yusenko, M.V.1
Kuiper, R.P.2
Boethe, T.3
Ljungberg, B.4
van Kessel, A.G.5
-
41
-
-
0036467492
-
The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors
-
doi:10.1016/S0952-7915(01)00305-3
-
Taniguchi T, Takaoka A, (2002) The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 14: 111-116. doi:10.1016/S0952-7915(01)00305-3. PubMed: 11790540.
-
(2002)
Curr Opin Immunol
, vol.14
, pp. 111-116
-
-
Taniguchi, T.1
Takaoka, A.2
-
42
-
-
84876575052
-
Interferome v2.0: an updated database of annotated interferon-regulated genes
-
Rusinova I, Forster S, Yu S, Kannan A, Masse M, et al. (2012) Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res 41: D1040-D1046. PubMed: 23203888.
-
(2012)
Nucleic Acids Res
, vol.41
-
-
Rusinova, I.1
Forster, S.2
Yu, S.3
Kannan, A.4
Masse, M.5
-
43
-
-
33846933267
-
Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7
-
Balachandran S, Venkataraman T, Fisher PB, Barber GN, (2007) Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7. J Immunol 178: 2429-2439. PubMed: 17277150.
-
(2007)
J Immunol
, vol.178
, pp. 2429-2439
-
-
Balachandran, S.1
Venkataraman, T.2
Fisher, P.B.3
Barber, G.N.4
-
44
-
-
80055092195
-
Defining emerging roles for NF-kappaB in antivirus responses: revisiting the interferon-beta enhanceosome paradigm
-
Balachandran S, Beg AA, (2011) Defining emerging roles for NF-kappaB in antivirus responses: revisiting the interferon-beta enhanceosome paradigm. PLOS Pathog 7: e1002165.
-
(2011)
PLOS Pathog
, vol.7
-
-
Balachandran, S.1
Beg, A.A.2
-
45
-
-
0035344461
-
A weak signal for strong responses: interferon-alpha/beta revisited
-
doi:10.1038/35073080
-
Taniguchi T, Takaoka A, (2001) A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2: 378-386. doi:10.1038/35073080. PubMed: 11331912.
-
(2001)
Nat Rev Mol Cell Biol
, vol.2
, pp. 378-386
-
-
Taniguchi, T.1
Takaoka, A.2
-
46
-
-
84857415635
-
Constitutive type I interferon modulates homeostatic balance through tonic signaling
-
doi:10.1016/j.immuni.2012.01.011
-
Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE, (2012) Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36: 166-174. doi:10.1016/j.immuni.2012.01.011. PubMed: 22365663.
-
(2012)
Immunity
, vol.36
, pp. 166-174
-
-
Gough, D.J.1
Messina, N.L.2
Clarke, C.J.3
Johnstone, R.W.4
Levy, D.E.5
-
47
-
-
0031657551
-
How cells respond to interferons
-
doi:10.1146/annurev.biochem.67.1.227
-
Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD, (1998) How cells respond to interferons. Annu Rev Biochem 67: 227-264. doi:10.1146/annurev.biochem.67.1.227. PubMed: 9759489.
-
(1998)
Annu Rev Biochem
, vol.67
, pp. 227-264
-
-
Stark, G.R.1
Kerr, I.M.2
Williams, B.R.3
Silverman, R.H.4
Schreiber, R.D.5
-
48
-
-
22344432068
-
Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations
-
doi:10.4161/cbt.3.12.1459
-
Stoyanova R, Clapper ML, Bellacosa A, Henske EP, Testa JR, et al. (2004) Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations. Cancer Biol Ther 3: 1313-1321. doi:10.4161/cbt.3.12.1459. PubMed: 15662135.
-
(2004)
Cancer Biol Ther
, vol.3
, pp. 1313-1321
-
-
Stoyanova, R.1
Clapper, M.L.2
Bellacosa, A.3
Henske, E.P.4
Testa, J.R.5
-
49
-
-
66349100709
-
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney
-
doi:10.1158/0008-5472.CAN-09-0146
-
Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, et al. (2009) Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res 69: 4674-4681. doi:10.1158/0008-5472.CAN-09-0146. PubMed: 19470766.
-
(2009)
Cancer Res
, vol.69
, pp. 4674-4681
-
-
Beroukhim, R.1
Brunet, J.P.2
Di Napoli, A.3
Mertz, K.D.4
Seeley, A.5
-
50
-
-
58149202128
-
Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls
-
doi:10.1038/nrd2781
-
Baud V, Karin M, (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8: 33-40. doi:10.1038/nrd2781. PubMed: 19116625.
-
(2009)
Nat Rev Drug Discov
, vol.8
, pp. 33-40
-
-
Baud, V.1
Karin, M.2
-
51
-
-
80052014052
-
Inflammation meets cancer, with NF-kappaB as the matchmaker
-
doi:10.1038/ni.2060
-
Ben-Neriah Y, Karin M, (2011) Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 12: 715-723. doi:10.1038/ni.2060. PubMed: 21772280.
-
(2011)
Nat Immunol
, vol.12
, pp. 715-723
-
-
Ben-Neriah, Y.1
Karin, M.2
-
52
-
-
33750432183
-
Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression
-
doi:10.1038/sj.onc.1209942
-
Bassères DS, Baldwin AS, (2006) Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25: 6817-6830. doi:10.1038/sj.onc.1209942. PubMed: 17072330.
-
(2006)
Oncogene
, vol.25
, pp. 6817-6830
-
-
Bassères, D.S.1
Baldwin, A.S.2
-
53
-
-
0029617947
-
Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome
-
doi:10.1016/0092-8674(95)90136-1
-
Thanos D, Maniatis T, (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83: 1091-1100. doi:10.1016/0092-8674(95)90136-1. PubMed: 8548797.
-
(1995)
Cell
, vol.83
, pp. 1091-1100
-
-
Thanos, D.1
Maniatis, T.2
-
54
-
-
0037053327
-
Stimulation of IRF-7 gene expression by tumor necrosis factor alpha: requirement for NFkappa B transcription factor and gene accessibility
-
doi:10.1074/jbc.M111440200
-
Lu R, Moore PA, Pitha PM, (2002) Stimulation of IRF-7 gene expression by tumor necrosis factor alpha: requirement for NFkappa B transcription factor and gene accessibility. J Biol Chem 277: 16592-16598. doi:10.1074/jbc.M111440200. PubMed: 11877397.
-
(2002)
J Biol Chem
, vol.277
, pp. 16592-16598
-
-
Lu, R.1
Moore, P.A.2
Pitha, P.M.3
-
55
-
-
17144404177
-
IRF-7 is the master regulator of type-I interferon-dependent immune responses
-
doi:10.1038/nature03464
-
Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777. doi:10.1038/nature03464. PubMed: 15800576.
-
(2005)
Nature
, vol.434
, pp. 772-777
-
-
Honda, K.1
Yanai, H.2
Negishi, H.3
Asagiri, M.4
Sato, M.5
|